GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SillaJen Inc (XKRX:215600) » Definitions » Beneish M-Score

SillaJen (XKRX:215600) Beneish M-Score : -2.34 (As of Apr. 24, 2025)


View and export this data going back to 2016. Start your Free Trial

What is SillaJen Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.34 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for SillaJen's Beneish M-Score or its related term are showing as below:

XKRX:215600' s Beneish M-Score Range Over the Past 10 Years
Min: -9.71   Med: -2.94   Max: 15.84
Current: -2.34

During the past 11 years, the highest Beneish M-Score of SillaJen was 15.84. The lowest was -9.71. And the median was -2.94.


SillaJen Beneish M-Score Historical Data

The historical data trend for SillaJen's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SillaJen Beneish M-Score Chart

SillaJen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.07 -1.96 15.84 -4.66 -2.34

SillaJen Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.66 -3.93 -2.35 -1.75 -2.34

Competitive Comparison of SillaJen's Beneish M-Score

For the Biotechnology subindustry, SillaJen's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SillaJen's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SillaJen's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where SillaJen's Beneish M-Score falls into.


;
;

SillaJen Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of SillaJen for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.7184+0.528 * 0.8825+0.404 * 0.4927+0.892 * 0.9967+0.115 * 0.9262
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.85+4.679 * -0.058353-0.327 * 0.4598
=-2.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Total Receivables was ₩814 Mil.
Revenue was 1526.632 + 1290.884 + 806.943 + 302.195 = ₩3,927 Mil.
Gross Profit was -1672.736 + 1290.884 + -394.835 + 136.531 = ₩-640 Mil.
Total Current Assets was ₩126,119 Mil.
Total Assets was ₩149,016 Mil.
Property, Plant and Equipment(Net PPE) was ₩1,739 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩939 Mil.
Selling, General, & Admin. Expense(SGA) was ₩11,742 Mil.
Total Current Liabilities was ₩16,600 Mil.
Long-Term Debt & Capital Lease Obligation was ₩566 Mil.
Net Income was -6888.103 + -7867.413 + -6707.53 + -5062.7 = ₩-26,526 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ₩0 Mil.
Cash Flow from Operations was -1862.234 + -5075.85 + -5733.024 + -5159.177 = ₩-17,830 Mil.
Total Receivables was ₩475 Mil.
Revenue was -1170.314 + 1718.423 + 2595.103 + 796.347 = ₩3,940 Mil.
Gross Profit was -3653.129 + 1718.423 + 1163.597 + 204.319 = ₩-567 Mil.
Total Current Assets was ₩52,228 Mil.
Total Assets was ₩76,715 Mil.
Property, Plant and Equipment(Net PPE) was ₩2,381 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩1,146 Mil.
Selling, General, & Admin. Expense(SGA) was ₩6,368 Mil.
Total Current Liabilities was ₩10,243 Mil.
Long-Term Debt & Capital Lease Obligation was ₩8,976 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(813.904 / 3926.654) / (475.194 / 3939.559)
=0.207277 / 0.120621
=1.7184

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(-566.79 / 3939.559) / (-640.156 / 3926.654)
=-0.143871 / -0.163028
=0.8825

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (126119.217 + 1738.635) / 149015.779) / (1 - (52227.813 + 2381.33) / 76714.902)
=0.141984 / 0.288155
=0.4927

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=3926.654 / 3939.559
=0.9967

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1145.775 / (1145.775 + 2381.33)) / (939.246 / (939.246 + 1738.635))
=0.324849 / 0.350742
=0.9262

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(11741.829 / 3926.654) / (6367.683 / 3939.559)
=2.990289 / 1.616344
=1.85

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((565.906 + 16600.096) / 149015.779) / ((8976.23 + 10242.618) / 76714.902)
=0.115196 / 0.250523
=0.4598

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-26525.746 - 0 - -17830.285) / 149015.779
=-0.058353

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

SillaJen has a M-score of -2.34 suggests that the company is unlikely to be a manipulator.


SillaJen Beneish M-Score Related Terms

Thank you for viewing the detailed overview of SillaJen's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


SillaJen Business Description

Traded in Other Exchanges
N/A
Address
6F, 252, Geumjeong-ro, Geumjeong-gu, Busan, KOR, 46274
SillaJen Inc is a Korean based biotechnology company focused on engineering and developing cancer treatment cells. The company along with its subsidiary SillaJen Biotherapeutics, Inc offers Pexa-Vec, an oncolytic virus with antibodies, and improved survival in a randomized trial to cure cancer; and JX929, an engineered vaccinia virus strain that acts on cancer cells by viral attack and subsequent cancer cell oncolysis. SillaJen operates its business activities in Korea and United States.

SillaJen Headlines

No Headlines